Application Note: A new way to study cytokine release syndrome
17 November 2021

Our own immune systems can endanger us when they respond incorrectly or overreact to stimuli. Severe allergic reactions, rheumatoid arthritis, type 1 diabetes, and lupus are just a few familiar examples of immune responses gone wrong. Many drug developers and clinical researchers are especially concerned with another category of the disordered immune response: cytokine release syndrome (CRS). In this application note by The Jackson Laboratory, find out about CRS and the advantages of the in vivo CRS evaluation study over the traditional methods.